Obsessive-Compulsive Disorder (Ocd) Investigational Medication

Brief Description Of Study

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking an SRI medication for their OCD but still have unwanted symptoms.

Detailed Study Description

The Center for the Treatment and Study of Anxiety is offering an investigational medication for people who have obsessive-compulsive disorder (OCD) and are currently taking one of the below medications for their OCD but still have unwanted symptoms. 



Are you taking one of the following medications for obsessive-compulsive disorder?


    • Clomipramine (Anafranil)
    • Fluoxetine (Prozac)
    • Fluvoxamine (Luvox)
    • Sertraline (Zoloft)
    • Paroxetine (Paxil)
    • Citalopram (Celexa)
    • Escitalopram (Lexapro)



Eligible participants remain on a stable dose of their OCD medication in the first part of the study, and will receive an investigational medication or a placebo as additional treatment for 10 weeks. Individuals who do not improve will be referred elsewhere to receive appropriate clinical treatment.

 

Men and women ages 18-75 with OCD who are currently taking an SRI medication (Prozac, Zoloft, Paxil, Luvox, Celexa, Lexapro or Anafranil) may be eligible to participate in this study.  There is no cost for this study. Participants may be compensated to $525 for their participation.


Additional Information About The Study

 If interested, contact Gina at gbelli@pennmedicine.upenn.edu to receive our initial eligibility screener.


Clinical Study Identifier: TX5918


Contact research investigator to learn more about this study by filling out the form below.


To: Research Study Investigator
Subject: I am interested in participating in your Research Study
Dear Investigator,
I'm interested in learning more about and participating in your research study named: Obsessive-compulsive disorder (OCD) Investigational Medication
I am hoping to hear back from you and discuss details of the study

By clicking "Contact Research Team", your contact information will be sent directly to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.